Physician profile
Chandra Marlin
NPI 1881237808
$2,045.13
in general payments reported to CMS, 2019-2025
36 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $114 · 2022: $478 · 2023: $591 · 2024: $597 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,434 · Education: $19.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,434.26 |
| Education | $19.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $320.40 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $214.47 | 2022-2025 | |
| 180 Medical, INC. | $136.79 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $109.65 | 2021-2023 | Aveed, Xiaflex, Edex |
| Axonics, INC. | $109.30 | 2023-2024 | Axonics, Bulkamid |
| Myovant Sciences INC. | $109.15 | 2021-2022 | |
| Accord Healthcare, INC. | $106.80 | 2023-2024 | |
| Rochester Medical Corporation | $86.91 | 2022 | |
| Progenics Pharmaceuticals, INC. | $84.65 | 2023-2025 | Pylarify |
| Antares Pharma, INC. | $58.85 | 2024 | Xyosted |
| Astellas Pharma US INC | $56.63 | 2021-2025 | Xtandi |
| Calyxo, INC. | $45.73 | 2025 | Cvac Aspiration System |
| Sun Pharmaceutical Industries INC. | $42.67 | 2022-2023 | Yonsa |
| Dentsply Ih INC. | $41.94 | 2022 | |
| Solventum Corporation | $40.49 | 2024 | Prevena, 3m Cavilon, V.A.C. Veraflo Cleanse Choice |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $37.87 | 2024 | Xiaflex, Aveed |
| Medtronic, INC. | $37.85 | 2023 | Interstim |
| Vertex Pharmaceuticals Incorporated | $36.11 | 2025 | |
| Myriad Genetic Laboratories, INC. | $35.53 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $29.39 | 2024 | Provenge |
| Tolmar, INC. | $27.58 | 2024 | |
| Procept Biorobotics Corporation | $27.10 | 2023 | Aquabeam Robotic System |
| Sagent Pharmaceuticals | $26.06 | 2022-2023 | Glydo |
| Boston Scientific Corporation | $24.62 | 2023 | |
| Urovant Sciences INC | $21.42 | 2022 | |
| Urogen Pharma, INC. | $20.49 | 2025 | |
| Alnylam Pharmaceuticals INC. | $19.48 | 2023 | Oxlumo |
| Laborie Medical Technologies Corp. | $18.06 | 2022 | |
| Pfizer INC. | $17.78 | 2024 | |
| Janssen Biotech, INC. | $17.67 | 2022 | |
| Convatec INC. | $15.69 | 2021 | |
| Hollister Incorporated | $15.46 | 2023 | Infyna Chic, Vapro Plus Pocket |
| Coloplast Corp | $14.37 | 2021 | |
| Photocure INC | $13.62 | 2024 | Cysview |
| Abbvie INC. | $12.29 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandra Marlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.